2015
DOI: 10.1111/ced.12717
|View full text |Cite
|
Sign up to set email alerts
|

Facial multinucleate cell angiohistiocytoma: long-term remission with 585 nm pulsed dye laser

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 5 publications
0
9
0
Order By: Relevance
“…Surgical excision, cryotherapy, pulsed‐dye laser, argon laser, intense pulsed light, and carbon dioxide laser can also be considered and have all shown anecdotal efficacy . The rationale behind the use of intense pulsed light and pulsed‐dye laser is based on the vascular oxyhemoglobin targets notable in MCAH, and both modalities offer desirable non‐ablative approaches to interventional therapy . Additional studies may also be helpful in discovering newer treatment modalities that might achieve more consistent and long‐term remission.…”
Section: Discussionmentioning
confidence: 99%
“…Surgical excision, cryotherapy, pulsed‐dye laser, argon laser, intense pulsed light, and carbon dioxide laser can also be considered and have all shown anecdotal efficacy . The rationale behind the use of intense pulsed light and pulsed‐dye laser is based on the vascular oxyhemoglobin targets notable in MCAH, and both modalities offer desirable non‐ablative approaches to interventional therapy . Additional studies may also be helpful in discovering newer treatment modalities that might achieve more consistent and long‐term remission.…”
Section: Discussionmentioning
confidence: 99%
“…15 MCAH treatment is usually not necessary, and lesions can be successfully removed with surgical excision, argon laser, cryosurgery, carbon dioxide, intense pulsed light and 585 nm pulsed dye laser. 2,26,27 For generalized MCAH, no literature has been reported concerning the treatment. We first tried thalidomide (Changzhou Pharmaceutical Factory, Changzhou, China) 50 mg twice per day for our patient.…”
Section: Mcah Was First Identified By Smith and Wilsonmentioning
confidence: 99%
“…in middle‐aged to elderly women. Although the majority of these tumors have been described on the limbs, lesions have also been reported to distribute on the temple, face, eyelids, mucosa and vermilion of the lips . The arrangement of lesions tends to be solitary, multiple or grouped and shows a tendency to be unilateral.…”
mentioning
confidence: 99%
“…Richer and Lui 8 reported on a patient with a 4-year history of MCAH papules affecting the face that were treated with PDL monotherapy. Histologic examination before treatment found vascular proliferation.…”
Section: Discussionmentioning
confidence: 99%